首页> 美国卫生研究院文献>other >RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
【2h】

RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5

机译:RBM10促进小细​​胞肺癌的转化相关过程并受RBM5直接调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancers are the leading cause of cancer-related deaths worldwide, with small cell lung cancer (SCLC) being the most aggressive type. At the time of diagnosis, SCLC has usually already metastasized, and an astonishing 95% of patients eventually succumb to the disease. This highlights the need for more effective SCLC screening and treatment options. Interestingly, the earliest and most frequent genetic alteration associated with lung cancers involves a lesion in the region to which the RNA binding protein RBM5 maps. We have recently shown that a decrease in RBM5 expression may be a key step in SCLC development, as RBM5 regulated many transformation-associated processes in SCLC cells. RBM5 is structurally and functionally similar to another RNA binding protein, RBM10. Both proteins have tumor-suppressor properties in a variety of cancer cell lines, and it has been suggested that RBM5 expression can influence RBM10. Due to their similarities, and the recent evidence that RBM10 is mutated in up to 21% of lung cancers, we hypothesized that RBM10 would share RBM5’s tumor-suppressor properties in SCLC. Using transcriptome analysis and functional assays, we show, however, that RBM10’s function was opposite to what we hypothesized; in the endogenously RBM5-null GLC20 SCLC cell line, RBM10 actually promoted cell proliferation and other transformation-associated processes. Using RNA immunoprecipitation followed by next generation sequencing (RIP-Seq) and Western blotting, we demonstrate that RBM5 post-transcriptionally regulated RBM10 expression via direct interaction with specific RBM10 splice variants. We propose a working model describing the impact of this interaction on cellular processes. Our results provide evidence that RBM10 expression, in RBM5-null tumors, may contribute to tumor growth and metastasis. Measurement of both RBM10 and RBM5 expression in clinical samples may therefore hold prognostic and/or potentially predictive value.
机译:肺癌是世界范围内与癌症相关的死亡的主要原因,其中小细胞肺癌(SCLC)是最具攻击性的类型。在诊断时,SCLC通常已经转移,令人惊讶的95%的患者最终死于该疾病。这凸显了对更有效的SCLC筛查和治疗选择的需求。有趣的是,与肺癌相关的最早且最常见的遗传改变涉及RNA结合蛋白RBM5定位到的区域中的病变。我们最近发现,RBM5的表达可能是SCLC发展的关键步骤,因为RBM5调节了SCLC细胞中许多与转化相关的过程。 RBM5在结构和功能上类似于另一种RNA结合蛋白RBM10。这两种蛋白在多种癌细胞系中均具有肿瘤抑制特性,并且有人提出RBM5表达可以影响RBM10。由于它们的相似性以及最近的证据表明RBM10在高达21%的肺癌中发生了突变,我们假设RBM10在SCLC中将具有RBM5的肿瘤抑制特性。然而,通过转录组分析和功能分析,我们发现RBM10的功能与我们所假设的相反。在内源性RBM5无效的GLC20 SCLC细胞系中,RBM10实际上促进了细胞增殖和其他与转化相关的过程。使用RNA免疫沉淀,然后进行下一代测序(RIP-Seq)和Western印迹,我们证明RBM5通过与特定RBM10剪接变体的直接相互作用在转录后调节RBM10的表达。我们提出了一个工作模型,描述了这种相互作用对细胞过程的影响。我们的结果提供了证据,即RBM5无效的肿瘤中RBM10的表达可能有助于肿瘤的生长和转移。因此,对临床样品中RBM10和RBM5表达的测量都可能具有预后和/或潜在的预测价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号